Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYNZA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,031
Award facts
- Contract value 100% obligated
- $28,031.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections valued at $28,031.23 on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was awarded without set-aside provisions through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Pennsylvania. The delivery order represents a child contract under a larger indefinite delivery vehicle, leveraging the company's established federal procurement capabilities and pharmaceutical supply chain infrastructure.
This award falls under AmerisourceBergen Drug Corp's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The parent contract enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. Through this flexible contracting arrangement, AmerisourceBergen Drug Corp provides critical medical commodities to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zepbound, a GLP-1 receptor agonist indicated for chronic weight management, represents one of several specialized pharmaceutical products delivered under this strategic medical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FYNZA?
SPE2DB25FYNZA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FYNZA worth?
The government has obligated $28,031 on SPE2DB25FYNZA.
Is contract SPE2DB25FYNZA an order under another contract?
Yes. SPE2DB25FYNZA is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYNZA competed?
The extent of competition for SPE2DB25FYNZA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award